A phase 1b/2 dose escalation and expansion study of OP-1250 in combination with ribociclib or alpelisib in patients with advanced and/or metastatic estrogen receptor-positive (ER+)/HER2-negative (HER2-) breast cancer Meeting Abstract

International Collaboration

cited authors

  • Borges, Virginia F.; Chan, Arlene; Lin, Nancy U.; Tonda, Margaret Eleanor; Shilkrut, Mark; Alemany, Carlos A.

Publication Date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16